BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 10444209)

  • 1. New findings in pharmacological effects induced by antihistamines: from PET studies to knock-out mice.
    Yanai K; Okamura N; Tagawa M; Itoh M; Watanabe T
    Clin Exp Allergy; 1999 Jul; 29 Suppl 3():29-36; discussion 37-8. PubMed ID: 10444209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular imaging of histamine receptors in the human brain].
    Tashiro M; Yanai K
    Brain Nerve; 2007 Mar; 59(3):221-31. PubMed ID: 17370648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Functional neuropharmacology in the human brain using positron emission tomography: PET imaging of impaired cognitive performance induced by sedative antihistamines].
    Yanai K; Okamura N; Itoh M; Watanabe T
    Nihon Yakurigaku Zasshi; 1998 Oct; 112 Suppl 1():48P-52P. PubMed ID: 10190133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central effects of fexofenadine and cetirizine: measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography.
    Tashiro M; Sakurada Y; Iwabuchi K; Mochizuki H; Kato M; Aoki M; Funaki Y; Itoh M; Iwata R; Wong DF; Yanai K
    J Clin Pharmacol; 2004 Aug; 44(8):890-900. PubMed ID: 15286093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron emission tomographic study of central histamine H1-receptor occupancy in human subjects treated with epinastine, a second-generation antihistamine.
    Yanai K; Ryu JH; Watanabe T; Iwata R; Ido T; Asakura M; Matsumura R; Itoh M
    Methods Find Exp Clin Pharmacol; 1995 Nov; 17 Suppl C():64-9. PubMed ID: 8750798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A potential of positron emission tomography in the drug development of non-sedative antihistamines].
    Tashiro M; Yanai K
    Nihon Yakurigaku Zasshi; 2003 Nov; 122 Suppl():78P-80P. PubMed ID: 14727529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral histamine H1 receptor binding potential measured with PET under a test dose of olopatadine, an antihistamine, is reduced after repeated administration of olopatadine.
    Senda M; Kubo N; Adachi K; Ikari Y; Matsumoto K; Shimizu K; Tominaga H
    J Nucl Med; 2009 Jun; 50(6):887-92. PubMed ID: 19443589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of histamine in regulation of arousal and cognition: functional neuroimaging of histamine H1 receptors in human brain.
    Tashiro M; Mochizuki H; Iwabuchi K; Sakurada Y; Itoh M; Watanabe T; Yanai K
    Life Sci; 2002 Dec; 72(4-5):409-14. PubMed ID: 12467881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histamine H1 receptor occupancy in human brains after single oral doses of histamine H1 antagonists measured by positron emission tomography.
    Yanai K; Ryu JH; Watanabe T; Iwata R; Ido T; Sawai Y; Ito K; Itoh M
    Br J Pharmacol; 1995 Sep; 116(1):1649-55. PubMed ID: 8564232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histamine H1 receptors in schizophrenic patients measured by positron emission tomography.
    Iwabuchi K; Ito C; Tashiro M; Kato M; Kano M; Itoh M; Iwata R; Matsuoka H; Sato M; Yanai K
    Eur Neuropsychopharmacol; 2005 Mar; 15(2):185-91. PubMed ID: 15695063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain histamine H1 receptor occupancy measured by PET after oral administration of levocetirizine, a non-sedating antihistamine.
    Hiraoka K; Tashiro M; Grobosch T; Maurer M; Oda K; Toyohara J; Ishii K; Ishiwata K; Yanai K
    Expert Opin Drug Saf; 2015 Feb; 14(2):199-206. PubMed ID: 25466429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathecally-administered histamine facilitates nociception through tachykinin NK1 and histamine H1 receptors: a study in histidine decarboxylase gene knockout mice.
    Yoshida A; Mobarakeh JI; Sakurai E; Sakurada S; Orito T; Kuramasu A; Kato M; Yanai K
    Eur J Pharmacol; 2005 Oct; 522(1-3):55-62. PubMed ID: 16212954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain histamine H1 receptor occupancy of orally administered antihistamines, bepotastine and diphenhydramine, measured by PET with 11C-doxepin.
    Tashiro M; Duan X; Kato M; Miyake M; Watanuki S; Ishikawa Y; Funaki Y; Iwata R; Itoh M; Yanai K
    Br J Clin Pharmacol; 2008 Jun; 65(6):811-21. PubMed ID: 18410464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroimaging of histamine H1-receptor occupancy in human brain by positron emission tomography (PET): a comparative study of ebastine, a second-generation antihistamine, and (+)-chlorpheniramine, a classical antihistamine.
    Tagawa M; Kano M; Okamura N; Higuchi M; Matsuda M; Mizuki Y; Arai H; Iwata R; Fujii T; Komemushi S; Ido T; Itoh M; Sasaki H; Watanabe T; Yanai K
    Br J Clin Pharmacol; 2001 Nov; 52(5):501-9. PubMed ID: 11736858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New oral H1 antihistamines in children: facts and unmeet needs.
    de Benedictis FM; de Benedictis D; Canonica GW
    Allergy; 2008 Oct; 63(10):1395-404. PubMed ID: 18782118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomography evaluation of sedative properties of antihistamines.
    Yanai K; Zhang D; Tashiro M; Yoshikawa T; Naganuma F; Harada R; Nakamura T; Shibuya K; Okamura N
    Expert Opin Drug Saf; 2011 Jul; 10(4):613-22. PubMed ID: 21521134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered sleep-wake characteristics and lack of arousal response to H3 receptor antagonist in histamine H1 receptor knockout mice.
    Huang ZL; Mochizuki T; Qu WM; Hong ZY; Watanabe T; Urade Y; Hayaishi O
    Proc Natl Acad Sci U S A; 2006 Mar; 103(12):4687-92. PubMed ID: 16537376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced antinociception by intracerebroventricularly administered orexin A in histamine H1 or H2 receptor gene knockout mice.
    Mobarakeh JI; Takahashi K; Sakurada S; Nishino S; Watanabe H; Kato M; Naghdi N; Yanai K
    Pain; 2005 Nov; 118(1-2):254-62. PubMed ID: 16202530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The brain H3-receptor as a novel therapeutic target for vigilance and sleep-wake disorders.
    Parmentier R; Anaclet C; Guhennec C; Brousseau E; Bricout D; Giboulot T; Bozyczko-Coyne D; Spiegel K; Ohtsu H; Williams M; Lin JS
    Biochem Pharmacol; 2007 Apr; 73(8):1157-71. PubMed ID: 17288995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective cognitive dysfunction in mice lacking histamine H1 and H2 receptors.
    Dai H; Kaneko K; Kato H; Fujii S; Jing Y; Xu A; Sakurai E; Kato M; Okamura N; Kuramasu A; Yanai K
    Neurosci Res; 2007 Feb; 57(2):306-13. PubMed ID: 17145090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.